61 results
PRE 14A
HLVX
HilleVax Inc
12 Apr 24
Preliminary proxy
4:05pm
, from 2010 to 2015, Dr. Dubin served as VP and Head, Late Clinical Development at GlaxoSmithKline Vaccines, where he was responsible for the clinical … of the Executive Committee and was responsible for all business development related activities across the company and management of business alliances
8-K
EX-99.1
u0ws3
8 Jan 24
Regulation FD Disclosure
7:05am
8-K
EX-3.2
tu4b3ta65nlqoykj
8 Dec 23
Amendments to Articles of Incorporation or Bylaws
5:11pm
8-K
EX-3.1
vwpyz90ux6rb4cvbpug
8 Dec 23
Amendments to Articles of Incorporation or Bylaws
5:11pm
8-K
EX-1.1
4a7ay799uqteiybwai7
20 Sep 23
HilleVax Announces Proposed Public Offering of Common Stock
4:03pm
424B5
s4gm 9vhgrcgxcpw257p
20 Sep 23
Prospectus supplement for primary offering
4:01pm
424B5
qfgrjwfj6wtohgyrsuz
19 Sep 23
Prospectus supplement for primary offering
4:18pm